on Pace® Analytical
Pace® Life Sciences Receives Positive FDA Inspection Results in San German, Puerto Rico
Pace® Life Sciences, LLC, a comprehensive contract development and manufacturing organization, recently announced a favorable review from the US Food & Drug Administration (FDA). This outcome follows a meticulous three-day inspection of the company's quality systems and data delivery processes at its San German, Puerto Rico laboratory. Lou Forcellini, the Head of Quality Assurance at Pace® Life Sciences, indicated the inspection's success underlines the laboratory’s commitment to quality and data integrity.
The San German operation boasts over 60 bilingual chemists and microbiologists, showcasing extensive expertise in pharmaceutical and medical device support on a global scale. In 2023, this facility achieved an industry-leading average project turnaround time of 10 working days. Services provided include a variety of testing protocols and quality assurance processes, aiming at compliance with both the US FDA and the Drug Enforcement Agency (DEA). This inspection affirms Pace® Life Sciences' long-standing dedication to quality as it heads into 2024.
R. E.Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Pace® Analytical news